Agoracom Blog Home

Posts Tagged ‘investing’

Hong-Kong listed H&H leads a $25.7M investment in ELSE Nutrition $BABY.ca $ABT $TSN $CAG

Posted by AGORACOM-JC at 7:17 AM on Tuesday, October 13th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

The global baby & adult nutrition company increases its strategic capital stake in ELSE to $9.75M via its subsidiary NewH2 Limited

  • NewH2 Limited, a subsidiary of Health and Happiness (H&H) International Holdings Limited, a Hong Kong Stock Exchange listed company (1112.HK) has increased their strategic investment in Else by C$4.0 million pursuant to a non-brokered private placement announced on September 15th.
  • With the completion this financing NewH2 owns 10,678,706 shares of the Company and 3,114,121 warrants, which will represent approximately 11.6% of the Company’s issued and outstanding common shares
  • Else intends to use the proceeds of the offering to market its novel, plant-based baby and toddler nutrition products in North America alongside new product development operations.

VANCOUVER, BC / October 13, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is announcing today that NewH2 Limited, a subsidiary of Health and Happiness (H&H) International Holdings Limited, a Hong Kong Stock Exchange listed company (1112.HK) has increased their strategic investment in Else by C$4.0 million pursuant to a non-brokered private placement announced on September 15th.

The Company intends to use the proceeds of the offering to market its novel, plant-based baby and toddler nutrition products in North America alongside new product development operations. Furthermore, the investment provides the Company with the ability to accelerate and increase its production and supply capabilities, increase marketing activities and introduce its product(s) in new territories globally.

“We are very excited to continue to expand our relationship with H&H. They have been an immensely valuable partner and we look forward to working with their team in new market regions. We hear regularly from families across the globe who are seeking a non-dairy nutrition alternative for their children and we are fortunate to have a global partner supporting our endeavours for introduction of our products to store shelves in North America and beyond,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

Pursuant to the private placement the Company issued 2,224,111 (the “Units”) at a price of C$2.25 per Unit. Each Unit consisting of one common share and 0.50 share purchase warrants, with each whole warrant (a “Warrant”) entitling the holder to acquire one additional common share of the Company at an exercise price of C$3.25 per share for a period of thirty months from the closing date. With the completion this financing NewH2 owns 10,678,706 shares of the Company and 3,114,121 warrants, which will represent approximately 11.6% of the Company’s issued and outstanding common shares. The units issued will be subject to a 12 month hold period from date of closing.

The Company also pleased to announce that it has closed its previously announced upsized bought deal public offering, lead by Canaccord Genuity, of units (the “Units“) for ‎aggregate gross proceeds of CAD$20.7 million, including the exercise of the over-allotment option in full (the “Offering“). The Company issued ‎‎9,200,000 Units at a price of CAD$2.25 per Unit, each Unit consisting of one common share of the ‎Company (a “Share“) and one-half of one common share purchase warrant, with each whole warrant (a “Warrant“) ‎entitling the holder to purchase one Share at the price of CAD$3.25 per Share until October 6, 2022. ‎The Company has received approval from the TSX Venture Exchange (“TSXV“) to list the Warrants issued pursuant to the Offering, and the Warrants are posted for trading on the TSXV under the ticker symbol “BABY.WT” effective October 8, 2020.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for sale on Else’s e-store at elsenutrition.com, and will soon be available on Amazon.com. Consumers can order single 22 oz cans and 4-packs.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

Else Nutrition $BABY.ca Announces Closing of $20.7 Million Upsized Bought Deal Public Offering and Concurrent $5 million Private Placement $BMY $ABT $TSN $CAG

Posted by AGORACOM-JC at 10:07 AM on Tuesday, October 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Closed its previously announced upsized bought deal public offering of units for ‎aggregate gross proceeds of approximately CAD$20.7 million, including the exercise of the over-allotment option in full
  • The Company issued ‎‎9,200,000 Units at a price of CAD$2.25 per Unit, each Unit consisting of one common share of the ‎Company and one-half of one common share purchase warrant, with each whole warrant entitling the holder to purchase one Share at the price of CAD$3.25 per Share until October 6, 2022
  • In total, the Company received gross proceeds of approximately CAD$25.7 million from the closing of the Offering and Private Placement

VANCOUVER, BC / October 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), is pleased to announce that it has closed its previously announced upsized bought deal public offering of units (the “Units“) for ‎aggregate gross proceeds of approximately CAD$20.7 million, including the exercise of the over-allotment option in full (the “Offering“). The Company issued ‎‎9,200,000 Units at a price of CAD$2.25 per Unit, each Unit consisting of one common share of the ‎Company (a “Share“) and one-half of one common share purchase warrant, with each whole warrant (a “Warrant“) ‎entitling the holder to purchase one Share at the price of CAD$3.25 per Share until October 6, 2022. ‎The Company has received approval from the TSX Venture Exchange (“TSXV“) to list the Warrants issued pursuant to the Offering, and the Warrants are expected to be listed and posted for trading on the TSXV under the ticker symbol “BABY.WT” effective on or about October 8, 2020.

Concurrent with the Offering, the Company issued 2,224,111 Units on a private placement basis, for additional gross proceeds of approximately CAD$5 million (the “Private Placement“). New H2 Limited (“New H2“), a wholly owned subsidiary of Health and Happiness (H&H) International Holdings Ltd, a Hong Kong Stock Exchange company (HK:1112), subscribed for CAD$4,000,000 worth of Units in the Private Placement pursuant to a previously disclosed investor rights agreement dated March 2, 2020 between the Company and New H2.

In total, the Company received gross proceeds of approximately CAD$25.7 million from the closing of the Offering and Private Placement.

The Offering was conducted on a bought deal basis by Canaccord Genuity Corp. and Haywood ‎Securities Inc. (collectively, the “Underwriters“). On closing, the Company issued to the Underwriters an aggregate ‎of 597,920 broker warrants (the “Broker Warrants“), each Broker Warrant entitling the holder to ‎purchase one Share at the price of CAD$2.25 per Share until October 6, 2022.‎

The Units issued pursuant to the Offering were offered by way of a short form prospectus filed in all provinces of Canada except Quebec and elsewhere on a private placement basis. The Company intends to use the net proceeds of the Offering and the Private Placement for marketing, distribution, inventory and general corporate purposes.

All securities issued in connection with the Private Placement are subject to a four month hold period pursuant to the policies of the TSX Venture Exchange and applicable securities laws.

The securities offered have not been, nor will they be, registered under the U.S Securities Act of 1933 (the “U.S. Securities Act“) or any ‎state securities laws, and may not be offered or sold in the United States or to, or for the account or ‎benefit of, any person in the United States or to U.S. Persons (as such term is defined in Regulation S ‎under the U.S. Securities Act) absent registration or an applicable exemption from the registration ‎requirements. This news release will not constitute an offer to sell or the solicitation of an offer to buy ‎nor will there be any sale of the securities in any state in which such offer, solicitation or sale would be ‎unlawful.‎

MI 61-101

New H2’s subscription for Units in the Private Placement constitutes a “related party transaction” within the meaning of TSXV Policy 5.9 and Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The transaction is exempt from the formal valuation requirements of MI 61-101 pursuant to section 5.5(a) and the minority shareholder approval requirements of MI 61-101 pursuant to section 5.7(1)(a) as the fair market value of the related party’s subscription will not be more than 25% of the Company’s market capitalization. The Company will be filing a material change report in respect of the related party transaction on SEDAR less than 21 days prior to the closing of the transaction due to the fact that the Company wished to close the transaction as soon as possible.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For additional information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements relating to the trading date of the Warrants and the intended use of the net proceeds of ‎the Offering and the Private Placement. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

KWESST $KWE.ca Electronic Decoy Patent Receives Notice of Allowance from U.S. Patent Office $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 3:28 PM on Monday, October 5th, 2020
  • Announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the Company’s patent application covering its PhantomTM electronic battlefield decoy
  • Notice of Allowance from the USPTO covers fifteen patent claims for a programmable multi-waveform radio frequency generator capable of broadcasting and emulating all relevant military waveforms to create electronic battlefield decoys that deceive adversaries regarding the location of NATO friendly forces

Ottawa, Ontario–(October 5, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for the Company’s patent application covering its PhantomTM electronic battlefield decoy.

“This marks an important addition to KWESST’s technology portfolio,” said Jeff MacLeod, President and CEO, who added that, “The allowed claims cover both the miniaturized device itself and methods of deploying it, which we believe constitute significant protection of the invention.”

KWESST’s PhantomTM system addresses the latest requirements for miniaturized electronic decoys that can be easily deployed by soldiers or drones in contested areas of operation to prevent adversaries from accurately locating NATO forces. “Owning the patent that protects both the technology and the method of deployment gives KWESST a distinct advantage in a vast emerging market of next-generation electronic countermeasures,” said the Company.

The Notice of Allowance from the USPTO covers fifteen patent claims for a programmable multi-waveform radio frequency generator capable of broadcasting and emulating all relevant military waveforms to create electronic battlefield decoys that deceive adversaries regarding the location of NATO friendly forces.

The Company added that it is filing additional claims by way of a “Continuance” to expand the scope of its patent even further.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE.

Contact: Jason Frame, Investor Relations. Email: [email protected]

Else Nutrition Holdings Inc. $BABY.ca to Webcast Live at VirtualInvestorConfences October 8th $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:18 AM on Monday, October 5th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

VANCOUVER, BC / October 5, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition today announced that [Hamutal Yitzhak], [CEO], will present at VirtualInvestorConferences.com on October 8th.

DATE: Thursday, October 8th

TIME: 4:00 PM ET

LINK: https://bit.ly/3bLR2RF

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Recent Company Highlights

  1. Recent CAD $ 25M financing and use of proceeds
  2. Recent Amazon and website launch.
  3. Current US distribution agreements and updated plans for retail rollout.
  4. H&H Global Group, company’s largest investor increased their stake in the last round of financing, and the new territories distribution and expansion plans.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

Virtual Investor Conferences

John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

KWESST $KWE.ca Appoints Chief Financial Officer $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 4:46 PM on Thursday, October 1st, 2020
  • Announced the appointment of Steven Archambault, CPA, CA as the Company’s new Chief Financial Officer
  • Mr. Archambault brings a wealth of international finance experience to KWESST. With 15 years of public company experience, he has deep functional expertise and technical knowledge in all aspects of corporate finance, financial planning, and accounting, in addition to merger and acquisitions.
  • Mr. Archambault will commence immediately, replacing Paul Kania.

Ottawa, Ontario–(October 1, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced the appointment of Steven Archambault, CPA, CA as the Company’s new Chief Financial Officer.

Mr. Archambault brings a wealth of international finance experience to KWESST. With 15 years of public company experience, he has deep functional expertise and technical knowledge in all aspects of corporate finance, financial planning, and accounting, in addition to merger and acquisitions. Mr. Archambault will commence immediately, replacing Paul Kania.

Mr. Kania has been on contract as CFO since November 2019 to position the Company for its going public transaction and will remain available to KWESST as an advisor to facilitate the transition. David Luxton, Executive Chairman, thanked Mr. Kania on behalf of the board for his assistance in getting the Company to this milestone.

“We’re delighted to welcome Steven Archambault on board,” added Mr. Luxton. “He has the rare combination of experience and ability to contribute to the Company’s strategic agenda as well as ensure operational excellence as the Company grows from here.”

Steven Archambault commented, “I’m excited to be joining the KWESST leadership team at a time when the Company continues to gain traction with its disruptive technologies in the defence and security community, and the potential for outsized growth on a global scale with superior returns to shareholders.”

Mr. Archambault’s appointment will initially be on a part-time employment basis for the next six months with KWESST having the option to convert the employment to a full-time indefinite period.

In connection with his appointment, Mr. Archambault has been granted 250,000 options exercisable at a price of $0.75 until September 29, 2025.

Steven Archambault Bio

Mr. Archambault began his career as a CPA, CA with Ernst & Young LLP, followed by senior finance positions at AXIS Capital, a global insurer and reinsurer, and more recently had CFO roles with small cap public Canadian companies listed on the TSX-V and CSE in media broadcasting technology and health & wellness industries.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE.

Contact:
Jason Frame, Investor Relations.
Email: [email protected]

For more information please visit www.kwesst.com.

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST after giving effect to the Qualifying Transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

VIDEO – Soldier Launched Micro Drones, Electronic Soldier Decoys and a $93,000,000 Pipeline – Meet Brand New Listing KWESST Micro Systems $KWE.ca $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 9:17 AM on Thursday, October 1st, 2020

If you haven’t heard of KWESST Micro Systems (KWE:TSXV) you’re not alone because the Company just listed for trading a couple of weeks ago – and it is probably the coolest new listing of 2020 if you love high-tech, covert defense systems that we only get to see in Tom Cruise movies.

KWESST is a leader in “soldier systems” which are technologies that increase the capabilities of soldiers,  Let’s be clear right off the start, KWESST doesn’t sell weaponry.  Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.  

For example, out in a field of combat, soldiers emit Electro Magnetic (EM) signatures that make them detectable by enemy combatants.  KWESST has a battlefield decoy system that creates multiple false phantom signatures to spoof adversaries.  This picture is worth 1,000 words.  

 We could go on about many other such technologies created by KWESST but this is AGORACOM after all and we want to get down to the business of KWESST, the highlights of which are as follows:

  • A developer of next-generation systems for forces around the world, including those of NATO and its allies
  • A leadership team whose experience spans decades and hundreds of millions of dollars in military and homeland security contracts
  • A sales and distribution network of agents that spans the globe
  • Partnerships with globally recognized OEM’s, including Samsung
  • A sales pipeline that stands at $93,000,000 (not a typo) as of August 2020
  • Already generating revenues in 2020

And last but not least, a secret weapon in its Executive Chairman David Luxton, whose companies under his leadership have generated over $1,000,000,000 (Yes, BILLION).  

The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until  now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.  

Now you do.  Meet KWESST Micro Systems.  Watch this first ever interview with David Luxton himself to learn about where KWESST is going.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

CLIENT FEATURE: KWESST $KWE.ca A Leader in Defensive Technologies That Increase the Capabilities of Soldiers $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 4:23 PM on Tuesday, September 29th, 2020

(KWE:TSXV)

WHY KWESST? HERE’S SOME GREAT REASONS

1.   KWESST is a leader in defensive technologies that increase the capabilities of soldiers, including
those of NATO and its allies

2.  These technologies make a critical difference to soldier safety and effectiveness

3.  The Leadership team experience spans decades and hundreds of millions of dollars in military and homeland security contracts.

4.  KWESST develops next-generation systems for forces around the world, with a particular focus on special forces among NATO countries and their allies.

5.  KWESST partners with globally recognized equipment manufacturers to integrate its systems into their solutions to create high value-add products for global customers.

6.  KWESST provides small cap investors with a rare opportunity to invest in a high-growth, technology driven, global defence company with:

  • Tier-1 Customers
  • Global Customers
  • Proprietary Technologies
  • Diversified Product
  • Globally Renowned Executive Team With Massive Successful Track Records

FULL DISCLOSURE: Kwesst Micro Systems Inc. is an advertising client of AGORA Internet Relations Corp.

KWESST $KWE.ca Announces Pending Patent for Improved Digital Aiming Systems $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:29 AM on Thursday, September 24th, 2020
  • Confirmed the formalization of patent pending status of an invention which improves the accuracy of military weapons systems, utilizing a novel micro-optical and computer vision technology, branded “Polaris”
  • Polaris works with digital aiming systems for military weapons including the KWESST’s flagship Tactical And Situational Control System (TASCS) and its Integrated Fires Module (IFM) to achieve the kind of accuracy normally obtainable only with expensive “smart” weapons systems.
  • TASCS IFM and its Polaris enhancement are comprised of an app and simple snap-on device that turns traditional “dumb” weapons into “smart” weapons, without any modification to the weapons or ammunition

Ottawa, Ontario–(September 24, 2020) –  KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today confirmed the formalization of patent pending status of an invention which improves the accuracy of military weapons systems, utilizing a novel micro-optical and computer vision technology, branded “Polaris”.

Polaris works with digital aiming systems for military weapons including the KWESST’s flagship Tactical And Situational Control System (TASCS) and its Integrated Fires Module (IFM) to achieve the kind of accuracy normally obtainable only with expensive “smart” weapons systems. TASCS IFM and its Polaris enhancement are comprised of an app and simple snap-on device that turns traditional “dumb” weapons into “smart” weapons, without any modification to the weapons or ammunition.

KWESST President and CEO, Jeff MacLeod, commented that, “Polaris is an important enhancement to KWESST’s TASCS and IFM system, which we believe will make this whole technology set even more compelling for military customers as they seek to improve the precision and utility of existing weapons systems.” He added: “While developed to work with our TASCS IFM module, Polaris could be implemented on non-competing fire control systems sold by other manufacturers.”

As well, Polaris and TASCS IFM enhance safety since weapon system commanders receive an accurate visual indication of the point of impact, allowing them to monitor projected impact points and quickly adjust aiming for greater precision.

The TASCS and Polaris suite integrate seamlessly into Battlefield Management Applications (BMA), the software systems used by NATO and NATO allies’ militaries to disseminate information, plan operations, and provide general operational awareness.

Current military digital aiming systems for weapons can suffer from inaccuracy due to fluctuations in inertial navigation, GPS, and digital magnetic compass bearings, particularly when weapons are stationary for long periods of time. Polaris overcomes these inherent inaccuracies through digital aiming that is not affected by magnetic fields, shock or recoil, or “drift” in location bearings over time.

The key benefits of Polaris for military users include:

  • Faster time on target;
  • Improved first round effects and accuracy; and
  • Reduction in the number of rounds required to neutralize a target.

Improved accuracy and first round effects also mean a reduction in potential collateral damage.

About TASCS and IFM

TASCS is an app and snap-on weapon adaptor that streams situational awareness and targeting information from any source directly to soldiers’ smart devices and their weapons systems for a leap ahead in safer and more effective engagement of adversaries. IFM is the variant of TASCS that integrates this capability into many short-range and long-range weapons systems, including grenade launchers and mortars.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The Company’s current portfolio of unique proprietary offerings includes:

  • Its signature TASCSTM system (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons.
  • The autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact.
  • A Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel.
  • The PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries.

All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance.

The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE.

Contact: Jason Frame, Investor Relations

Email: [email protected]

For more information please visit https://kwesst.com/

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Else Nutrition $BABY.ca Launches World’s First Globally Patented, Plant-Based Toddler Nutrition Formula on #Amazon.com $AMZN $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:09 AM on Thursday, September 24th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Amazon to begin online sales of Else Soy free Plant-Based Toddler Nutrition in the U.S.
  • Expanding into the world’s largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic
  • Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store
  • Selling direct to consumers through online channels, is a major pillar of Else’s global go-to-market strategy
  • Furthermore, the Company’s Amazon store will provide a convenient alternative for parents who prefer shopping online.

VANCOUVER, BC / September 24, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), is pleased to announce that its novel, first of its kind plant-based soy free Complete & clean label Nutrition for Toddlers is now available for U.S customers via Amazon.com.

Else is expanding into the world’s largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic. Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store.

Selling direct to consumers through online channels, is a major pillar of Else’s global go-to-market strategy. Furthermore, the Company’s Amazon store will provide a convenient alternative for parents who prefer shopping online.

In addition to its own e-store and the new the Amazon.com store, the Company is aggressively pursuing new channels to bring its novel products to natural food and grocery store aisles and store shelves across the United States. Grocers are eager to satisfy consumer’s growing demand for natural, clean, non-dairy and healthy alternative product offerings in the Company’s product category. This is further amplified given the massive growth and demand they are currently experiencing as a result of stay at home orders and restaurant closures.

As a result of both a consumer demand – plant-based products continue to significantly outpace overall food sales in the U.S., fueling a significant growth opportunity for retailers.

“We’re thrilled to offer Else Nutrition’s products US nation wide on Amazon.com,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. “With the launch of our plant-based Toddler complete nutrition, we’ve been getting many requests from customers who want to purchase our product on Amazon.com. This is a tremendous convenience and accessibility boost using the world’s largest e-commerce platform – as we continue our singular focus to bring novel, plant-based, clean nutrition to families,” she added.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available on Amazon.com as both single (for US$36) and 4-pack (for US$136).

Canadian consumers can order Else’s products at www.elsenutrition.com.

To visit Else’s Amazon please see: https://www.amazon.com/dp/B08FM4NRMR/ref=cm_sw_r_wa_api_fab_ZBGAFb01N25NV

Else is pleased to announce that as of September 14, 2020, it retained Winning Media LLC (“Winning Media“) for digital marketing and advertising services. Winning Media will be engaged on a month to month term and will be compensated a total of USD$75,000 for its current scope of services. Neither Winning Media nor Else currently own securities in each other. The engagement is subject to approval from the TSX Venture Exchange.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media Contact:

Covet Consumer Business Unit
Gianna Totaro
[email protected]
P: 1-301-875-6574

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

KWESST $KWE.ca Completes First Phase of Contract Delivery For TASCS to U.S. Military Customer $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:32 AM on Tuesday, September 22nd, 2020
  • Announced the successful completion of the first phase of three deliverables under a contract to support a U.S. military customer featuring the Company’s signature Tactical Awareness and Situational Control System” (“TASCS”)
  • First deliverable under a $500,000 (CAD) contract demonstrated the TASCS Integrated Fires Module on mortars and the Augmented Weapon Sight, a system developed by AeroVironment Inc. and KWESST to provide real-time situational awareness and targeting information
  • “These important military exercises demonstrate the maturity of the TASCS system,” said KWESST CEO Jeff MacLeod

Ottawa, Ontario–(September 22, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced the successful completion of the first phase of three deliverables under a contract to support a U.S. military customer featuring the Company’s signature Tactical Awareness and Situational Control System” (“TASCS”).

This first deliverable under a $500,000 (CAD) contract demonstrated the TASCS Integrated Fires Module (“IFM”) on mortars and the Augmented Weapon Sight (“AWS”), a system developed by AeroVironment Inc. (“AeroVironment”) and KWESST to provide real-time situational awareness and targeting information. AWS streams Full Motion Video (“FMV”) from an overhead Unmanned Aerial Vehicle (“UAV” or “drone”) manufactured by AeroVironment into the TASCS architecture for the purpose of target identification, accurate first-shot hits and real-time Battle Damage Assessment (“BDA”). The AWS system has been an ongoing collaboration between KWESST and AeroVironment.

“These important military exercises demonstrate the maturity of the TASCS system,” said KWESST CEO Jeff MacLeod. “We are very pleased at the performance of the system and the valuable user feedback. We expect the next two contracted demonstration exercises later this year to attract added customer attention and the development of operating procedures that will be employed in more extensive exercises expected in early 2021.”

David Luxton, Executive Chairman, added, “Demonstration exercises like this with military customers are an important phase in the process towards potential introduction into service. It is very encouraging that this key U.S. military customer is scheduling additional exercises, and that at least two other NATO military customers have similar capability demonstration contracts under consideration.”

About TASCS, IFM and AWS

“TASCS” is an app and snap-on weapon adaptor that streams situational awareness and targeting information from any source directly to soldiers’ smart devices and their weapons systems for a leap ahead in safer and more effective engagement of adversaries. “IFM” is the variant of TASCS that integrates this capability into many short-range and long-range weapons systems, including grenade launchers and mortars. “AWS” utilizes the TASCS system to stream situational and targeting information from AeroVironment Unmanned Aerial Vehicles (“UAV”s, or “drones”) directly to the TASCS display on soldiers’ smart devices and weapons systems in real time.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE and trades on the TSXV under the symbol KWE.

Contact: Jason Frame, Investor Relations
Email: [email protected]
For more information please visit www.kwesst.com

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST after giving effect to the Qualifying Transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.